Cleopatra Hospitals GroupE Informe acción CASE:CLHO Capitalización de mercado
ج.م12.5b
Finanzas de la empresa + 5 Analistas
Cleopatra Hospitals Group S.A.E.
Informe acción CASE:CLHO
Capitalización de mercado: ج.م12.5b
Resumen de acción CLHO Cleopatra Hospitals Group S.A.E. gestiona hospitales en Egipto.
Recompensas Análisis de riesgos Ver todos los controles de riesgos Competidores de Cleopatra Hospitals Group S.A.E. Historial de precios y rendimiento
Resumen de todos los máximos históricos, cambios y caídas de precios de Cleopatra Hospitals GroupE Precios históricos de las acciones Precio actual de la acción ج.م8.65 Máximo en las últimas 52 semanas ج.م9.44 Mínimo de 52 semanas ج.م4.19 Beta 0.47 1Cambio en 1 mes -3.78% Variación en 3 meses 23.57% Cambio de 1 año 104.98% 3Variación en 3 años 76.53% Variación en 5 años 40.42% Variación desde la OPV -10.46%
Noticias y actualizaciones recientes
Price target increased by 11% to ج.م9.50 Oct 14
Investor sentiment improves as stock rises 19% Oct 11
Now 20% undervalued after recent price drop Sep 24
Second quarter 2024 earnings released Sep 03
Price target increased by 13% to ج.م8.56 Jul 15
Consensus EPS estimates increase by 20% Jun 26 Ver más actualizaciones
Price target increased by 11% to ج.م9.50 Oct 14
Investor sentiment improves as stock rises 19% Oct 11
Now 20% undervalued after recent price drop Sep 24
Second quarter 2024 earnings released Sep 03
Price target increased by 13% to ج.م8.56 Jul 15
Consensus EPS estimates increase by 20% Jun 26
First quarter 2024 earnings released: EPS: ج.م0.13 (vs ج.م0.066 in 1Q 2023) May 28
Investor sentiment improves as stock rises 15% May 27
Consensus revenue estimates increase by 13% Apr 16
Investor sentiment improves as stock rises 16% Mar 24
Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Mar 19
Investor sentiment improves as stock rises 18% Feb 19
Price target increased by 15% to ج.م6.98 Jan 23
Investor sentiment improves as stock rises 17% Dec 03
Third quarter 2023 earnings released Nov 27
Investor sentiment improves as stock rises 16% Oct 19
Second quarter 2023 earnings released: EPS: ج.م0.071 (vs ج.م0.044 in 2Q 2022) Sep 03
First quarter 2023 earnings released: EPS: ج.م0.07 (vs ج.م0.063 in 1Q 2022) Jul 11
Insufficient new directors May 01
Full year 2022 earnings released: EPS: ج.م0.23 (vs ج.م0.20 in FY 2021) Mar 21
Investor sentiment deteriorates as stock falls 17% Mar 15
Consensus EPS estimates fall by 11% Sep 22
Price target decreased to ج.م6.07 Sep 21
Second quarter 2022 earnings released: EPS: ج.م0.04 (vs ج.م0.057 in 2Q 2021) Aug 22
First quarter 2022 earnings: Revenues miss analyst expectations May 30
Cleopatra Hospital Group S.A.E. to Report Q4, 2021 Results on Mar 20, 2022 Mar 23
An unknown buyer acquired 8.78% stake in Cleopatra Hospital Group S.A.E. (CASE:CLHO) from Care Healthcare Ltd for EGP 709.84 million. Jan 06
Third quarter 2021 earnings: Revenues exceed analyst expectations Nov 22
Second quarter 2021 earnings released Aug 30
First quarter 2021 earnings released Jun 07
Consensus forecasts updated Apr 28
Full year 2020 earnings released Mar 23
New 90-day high: ج.م5.29 Feb 04
New 90-day high: ج.م5.04 Jan 13
Cleopatra Hospital Group S.A.E. (CASE:CLHO) entered into sale and purchase agreement to acquire Alameda Healthcare Group assets in Egypt from Alameda Healthcare. Dec 28
Price target lowered to ج.م6.24 Dec 26
New 90-day low: ج.م4.48 Dec 09
Third quarter 2020 earnings released: EPS ج.م0.049 Nov 23
Revenue beats expectations, earnings disappoint Nov 23
New 90-day low: ج.م4.54 Nov 02
Analysts update estimates Sep 22
First half earnings released Sep 11
Cleopatra Hospital Group S.A.E. (CASE:CLHO) signed an agreement to acquire 60% stake in assets and operations of Bedaya Hospital. Sep 10
New 90-day low - ج.م4.69 Sep 09 Rentabilidad de los accionistas CLHO EG Healthcare Mercado EG 7D 5.4% 5.4% 2.2% 1Y 105.0% 95.9% 34.7%
Ver rendimientos de los accionistas
Rentabilidad vs. Industria: CLHO superó a la industria EG Healthcare, que obtuvo un rendimiento del 95.9% el año pasado.
Rentabilidad vs. Mercado: CLHO superó al mercado EG, que obtuvo un rendimiento del 34.7% el año pasado.
Volatilidad de los precios Is CLHO's price volatile compared to industry and market? CLHO volatility CLHO Average Weekly Movement 6.3% Healthcare Industry Average Movement 6.3% Market Average Movement 5.4% 10% most volatile stocks in EG Market 9.7% 10% least volatile stocks in EG Market 3.9%
Precio estable de las acciones: CLHO no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de CLHO (6%) se ha mantenido estable durante el año pasado.
Acerca de la empresa Cleopatra Hospitals Group S.A.E. gestiona hospitales en Egipto. Sus hospitales prestan diversos servicios médicos, como cirugías, ingresos, supervisión médica, análisis, investigaciones, radiografías y servicios ambulatorios. La empresa también gestiona seis hospitales y dos policlínicas, así como una farmacia para pacientes hospitalizados y otra para pacientes ambulatorios.
Mostrar más Resumen de fundamentos de Cleopatra Hospitals Group S.A.E. ¿Cómo se comparan los beneficios e ingresos de Cleopatra Hospitals GroupE con su capitalización de mercado? Estadísticas fundamentales de CLHO Capitalización bursátil ج.م12.50b Beneficios(TTM ) ج.م453.53m Ingresos (TTM ) ج.م4.38b
27.6x Ratio precio-beneficio (PE)
2.9x Ratio precio-ventas (PS) Beneficios e Ingresos Estadísticas clave de rentabilidad del último informe de resultados (TTM) Cuenta de resultados (TTM ) de CLHO Ingresos ج.م4.38b Coste de los ingresos ج.م2.83b Beneficio bruto ج.م1.55b Otros gastos ج.م1.10b Beneficios ج.م453.53m
Últimos beneficios comunicados
Jun 30, 2024
Próxima fecha de beneficios
n/a
Beneficios por acción (BPA) 0.31 Margen bruto 35.38% Margen de beneficio neto 10.35% Ratio deuda/patrimonio 54.5%
¿Cómo se ha desempeñado CLHO a largo plazo?
Ver rendimiento histórico y comparativa
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
